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ABSTRACT 
 
This paper presents U-net based breast cancer metastases 
detection and classification in lymph nodes, as well as 
patient-level classification based on metastases detection. 
The whole pipeline can be divided into five steps: 
preprocessing and data argumentation, patch-based 
segmentation, post processing, slide-level classification, and 
patient-level classification. In order to reduce overfitting and 
speedup convergence, we applied batch normalization and 
dropout into U-Net. The final Kappa score reaches 0.902 on 
training data.   
 
Index Terms— Deep learning, Medical imaging, U-Net, 
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1. INTRODUCTION 
 
Deep learning has been successfully applied to many tasks 
including image processing [1], sound/voice processing [2], 
language translation [2]. Recent progress shows that deep 
learning can also be applied into medical image processing, 
such as MRI [3], CT, biopsy, endoscopy. In the field of 
pathology, most of work still need to be done manually by 
pathologist using microscopes. Therefore, such tasks are 
time-consuming and the results vary significantly depends on 
the skill and condition of individual pathologist. In particular, 
cancer metastases detection is very challenging and requires 
extensive microscopic assessment by pathologists as the size 
of tumor region can be very small.  
An automated solution would potentially reduce the 
workload of pathologists as well as reduce the subjectivity in 
diagnosis [4]. The goal of Camelyon17 is automated 
detection and classification of breast cancer metastases in 
whole-slide images of histological lymph node. As the size of 
tumor regions can be very small (< 200 cells), pathologists 
are often required using high magnification (20X ~ 40X) for 
detecting tumor cells. This requirement significantly 
increases the workload for pathologist and machine learning 
approaches as well.  
Although the goal of Camelyon17 Challenge is to 
determine a pN-stage for every patient in the test dataset 
based on sizes/numbers of positive lymph nodes in multiple 
slides (Macro: metastases > 2.0 mm; Micro: metastases > 0.2 
mm / 200 cells, < 2.0 mm), the foundation of such tasks is to 
accurate segment cancer cells from normal cells. As the size 
of biopsy digital image is very large, there is no way to 
segment a whole image in a single pass, patch-based 
training/test pipeline becomes standard for handling 
Gigapixel pathology images. There are two common 
approaches for addressing this segmentation problem. The 
first approach solves metastases segmentation problem by 
classification [5] [6]. The whole slide is divided into multiple 
overlapping patches. Patch with more than half cancer cells 
is labelled as a cancer patch (positive), otherwise as a normal 
patch (negative). Therefore, metastases segmentation can be 
generated by averaging over classification results for all 
patches. The second approach is based on patch segmentation 
[7]. It still generates many patches, then segment cancer cells 
from normal ones for each patch. In this work, we choose the 
follow second approach as metastases can be very small and 
may not be the major component in some patches.  
 
  
 
2. U-NET ARCHITECTURE 
 
Our segmentation (pixel-wise classification) is based on U-
Net architecture [8] as shown in Figure 1. 
 
 
 
 
 
Figure 1: Original U-Net architecture 
 
We made some necessary modifications in order to better 
fit our purpose. We changed the model input size from 
572*572*1 to 256*256*3 in order to accept RGB images. 
Consequently, the following layers are also altered 
accordingly. Since Camelyon16 and Camelyon17 only 
provides less than 200 positive slides with masks, we also 
added batch normalization and dropout to the original 
implementation of U-Net in order to reduce overfitting and 
speedup convergence.  
 
 
3. TRAINING PIPELINE 
 
Our model training pipeline can be divided into 5 steps: 
preprocessing and data argumentation, patch-based 
segmentation, post processing, slide-level classification, and 
patient-level classification. 
 
3.1. Preprocessing and data argumentation  
 
As many deep learning-based approaches, many efforts have 
been made on data processing. We used all negative slides 
and positive slides from Camelyon16 and Camelyon17 with 
masks. Before taking samples from original slides, we 
generated regions of interest (ROI) by combining results from 
contours and Otsu’s method [9] as shown in Figure 2. 
 
 
Figure 2: ROI detecting based on contours and Otsu 
 
We selected N patches of size 512*512 that covered all tumor 
regions, then randomly selected 4*N patches from normal 
regions from tumor slides as well as normal sides within 
region of interest (ROI). In the end, we oversampled tumor 
patches to 2*N. Therefore, the negative/positive ratio was 2. 
In order to add variability into training data, heavy data 
argumentation was used such as flip, HSV color 
argumentation. Finally, all patches were resized to size 
256*256. 
 
3.2. Patch-based segmentation  
 
We chose to use TensorFlow [10] implementation of U-Net.  
All positive and negative patches were sampled in advance; 
data argumentation was performed during training on the fly. 
Training data samples are shown in Figure 3. 
 
 
 
Figure 3: Training patch and corresponding mask without 
(top) and with argumentation (bottom) 
 
   We trained our model on Dell T630 server with 128G 
memory and 4 Titan X GPUs. Initially, the learning rate was 
set to 0.001, and reduced to 0.0001 after 20 epochs. The final 
segmentation performance is evaluated on independent 
validation slides (see Figure 4).  
 
 
 
Figure 4: Sample segmentation results 
 
3.3. Post processing  
 
The segmentation produces a heat mask with probability for 
each pixel being cancer/normal for each slide. We 
empirically selected a threshold value to separate tumor cells 
from normal ones.  We also conducted experiments with 
average filter to filter out noise. However, applying such filter 
may remove small isolated tumor regions. Therefore, we did 
not use average filter for slide-level classification.  
  
3.4. Slide-level classification  
 
After post processing, we obtained tumor regions. We 
adopted random forest approach with 16 hand crafted features 
mainly focused on the size of the tumor region. In order to 
reduce the bias introduced by manually selecting heat map 
threshold, our features are based on three different thresholds, 
namely 0.3, 0.5, 0.7, 0.9.   
    Figure 5 shows confusion matrix on validation data. It is 
worth to note that classification accuracy for ITC (tumor 
regions with size < 0.2 mm or < 200 cells) is very low, and 
ITC almost always be misclassified as negative. 
 
 
 
Figure 5: confusion matrix for slide-level classification on 
validation data (126 slides) 
 
3.5. Patient-level classification  
 
We did not perform additional training for patient-level 
classification. Rather, we followed simple Pathologic lymph 
node classification (pN-stage) standard defined in 
CAMELYON17 [4]. 
- pN0: No micro-metastases or macro-metastases or 
ITCs found. 
- pN0(i+): Only ITCs found. 
- pN1mi: Micro-metastases found, but no macro-
metastases found. 
- pN1: Metastases found in 1–3 lymph nodes, of 
which at least one is a macro-metastasis. 
- pN2: Metastases found in 4–9 lymph nodes, of 
which at least one is a macro-metastasis. 
4. SUMMARY OF UPDATE 
 
After initial submission, we revisited the segmentation results 
on validation data. The observations suggested following 
updates on this version. 
 
• We retrained our mode with updated data from 
Camelyon. 
• Instead of working on 40X magnification, we chose 
20X magnification for extracting patches for 
training and test. 
• We removed rotation-based augmentation and only 
applied HSV, brightness, flip based augmentations. 
• In order to speedup training, we selected all tumor 
slides with label (mask) from Camelyon17 and 
Camelyon16, and only selected normal slides from 
Cameylon17. Overall, we chose 209 tumor sides and 
313 normal sides.  
• We also applied oversampling on positive patches 
but also kept positive/negative ration as 3. 
Therefore, we introduced more negative samples to 
reduce false positive. 
• We included Camelyon16 testing slides as training 
data for slide-level classification. 
  
For slide-level classification, we introduced more features 
based on negative-density of biggest predict tumor region to 
capture neighborhood information. 
  
 
 
5. RESULT AND CONCLUSION 
 
We tested our pipeline on validation data and obtained Kappa 
score of 0.902. The final Kappa score is computed using 
scripts provide by Camelyon17. 
   Obviously, there are many room for improvement. We 
noticed that ITC is very hard to predict. This may due to the 
patterns of isolated tumor cells are somewhat unique, and 
there are not enough training data for the model to capture 
such pattern. By random sampling, we did not obtain enough 
negative samples on such special regions. Therefore, we 
should perform important sampling or hard mining to 
introduce more, harder patches into training data and make 
the model more focus on mistakes. Another way to improve 
model prediction accuracy can be applying model assembly.  
We are working on training models with different 
architectures, even combining classification approach with 
segmentation.  
         Overall, computer-aided diagnosis system will be one 
of the most useful applications of deep learning. A 
technology that improves the detection of tumors for breast 
cancer can be easily adopted for detecting many other types 
of diseases. 
 
 
  
6. REFERENCES 
 
 
[1]  J. Deng, W. Dong, R. Socher, L.-J. Li, K. Li and L. Fei-
Fei, "ImageNet: A Large-Scale Hierarchical Image 
Database," in IEEE Conference on Computer Vision 
and Pattern Recognition, Miami, 2009.  
[2]  I. Sutskever, O. Vinyals and Q. V. Le, "Sequence to 
Sequence Learning with Neural Networks," 
arXiv:1409.3215v3, 2014. 
[3]  S. Sarraf and G. Tofighi, "Deep learning-based pipeline 
to recognize Alzheimer's disease using fMRI data," in 
Future Technologies Conference , San Francisco, 
2016.  
[4]  CAMELYON17, "CAMELYON17 challenge," 2017. 
[Online]. Available: https://camelyon17.grand-
challenge.org/. [Accessed 1 2 2018]. 
[5]  Y. Liu, K. Gadepalli, M. Norouzi, G. E. Dahl, T. 
Kohlberger, A. Boyko, S. Venugopalan, A. Timofeev, 
P. Q. Nelson, G. S. Corrado, J. D. Hipp, L. Peng and 
M. C. Stumpe, "Detecting Cancer Metastases on 
Gigapixel Pathology Images," arXiv:1703.02442v2, 
2017. 
[6]  D. Wang, A. Khosla, R. Gargeya, H. Irshad and A. H. 
Beck, "Deep Learning for Identifying Metastatic Breast 
Cancer," arXiv:1606.05718v1. 
[7]  L.-C. Chen, G. Papandreou, I. Kokkinos, K. Murphy 
and A. L. Yuille, "DeepLab: Semantic Image 
Segmentation with Deep Convolutional Nets, Atrous 
Convolution, and Fully Connected CRFs," 
arXiv:1606.00915v2, 2016. 
[8]  O. Ronneberger, P.Fischer and T. Brox, "U-Net: 
Convolutional Networks for Biomedical Image 
Segmentation," Medical Image Computing and 
Computer-Assisted Intervention, vol. 9351, pp. 234--
241, 2015.  
[9]  N. Otsu, "A Threshold Selection Method from Gray-
Level Histograms," IEEE Transactions on Systems, 
Man, and Cybernetics , vol. 9, no. 1, pp. 62 -- 66, 1979.  
[10]  M. Abadi, A. Agarwal, P. Barham, E. Brevdo, Z. Chen, 
C. Citro, G. S. Corrado, A. Davis, J. Dean, M. Devin, 
S. Ghemawat, I. Goodfellow, A. Harp, G. Irving, M. 
Isard, Y. Jia, R. Jozefowicz and L, "TensorFlow: 
Large-Scale Machine Learning on Heterogeneous 
Distributed Systems," arXiv:1603.04467v2, 2016. 
 
 
 
 
 
 
 
 
  
 
 
 
 
